End-of-day quote
Bucharest S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
14
RON
|
-2.10%
|
|
-2.78%
|
-21.57%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
76.89
|
103.1
|
103.1
|
103.1
|
106
|
7,226
|
Enterprise Value (EV)
1 |
136.2
|
774.6
|
732
|
715.2
|
284.5
|
7,703
|
P/E ratio
|
2.68
x
|
3.15
x
|
-2.33
x
|
1.08
x
|
0.35
x
|
26.6
x
|
Yield
|
-
|
-
|
-
|
1.16%
|
35.7%
|
2.68%
|
Capitalization / Revenue
|
0.31
x
|
0.35
x
|
0.08
x
|
0.09
x
|
0.05
x
|
3.19
x
|
EV / Revenue
|
0.55
x
|
2.62
x
|
0.57
x
|
0.6
x
|
0.13
x
|
3.4
x
|
EV / EBITDA
|
3.3
x
|
11.9
x
|
6.49
x
|
2.81
x
|
0.42
x
|
18
x
|
EV / FCF
|
1.6
x
|
-1
x
|
15.3
x
|
75.9
x
|
0.96
x
|
-58.1
x
|
FCF Yield
|
62.6%
|
-100%
|
6.54%
|
1.32%
|
104%
|
-1.72%
|
Price to Book
|
0.35
x
|
0.32
x
|
0.37
x
|
0.28
x
|
0.19
x
|
3.99
x
|
Nbr of stocks (in thousands)
|
139,292
|
186,762
|
186,762
|
186,762
|
192,056
|
304,908
|
Reference price
2 |
0.5520
|
0.5520
|
0.5520
|
0.5520
|
0.5520
|
23.70
|
Announcement Date
|
4/27/18
|
4/25/19
|
4/29/20
|
4/28/21
|
4/29/22
|
3/27/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
246.7
|
295.4
|
1,281
|
1,192
|
2,261
|
2,264
|
EBITDA
1 |
41.24
|
65.25
|
112.8
|
254.7
|
684.7
|
428.7
|
EBIT
1 |
24.77
|
49.94
|
58.12
|
206.8
|
638.1
|
283.5
|
Operating Margin
|
10.04%
|
16.9%
|
4.54%
|
17.34%
|
28.22%
|
12.52%
|
Earnings before Tax (EBT)
1 |
36.07
|
38.97
|
-35.18
|
113.5
|
543.1
|
318.3
|
Net income
1 |
31.25
|
32.69
|
-44.17
|
95.14
|
485.5
|
271.6
|
Net margin
|
12.67%
|
11.06%
|
-3.45%
|
7.98%
|
21.48%
|
12%
|
EPS
2 |
0.2057
|
0.1750
|
-0.2365
|
0.5094
|
1.592
|
0.8900
|
Free Cash Flow
1 |
85.26
|
-775.6
|
47.86
|
9.423
|
297
|
-132.6
|
FCF margin
|
34.57%
|
-262.53%
|
3.74%
|
0.79%
|
13.14%
|
-5.86%
|
FCF Conversion (EBITDA)
|
206.75%
|
-
|
42.43%
|
3.7%
|
43.38%
|
-
|
FCF Conversion (Net income)
|
272.8%
|
-
|
-
|
9.9%
|
61.17%
|
-
|
Dividend per Share
|
-
|
-
|
-
|
0.006400
|
0.1968
|
0.6363
|
Announcement Date
|
4/27/18
|
4/25/19
|
4/29/20
|
4/28/21
|
4/29/22
|
3/27/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
59.3
|
672
|
629
|
612
|
178
|
476
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.439
x
|
10.29
x
|
5.576
x
|
2.403
x
|
0.2607
x
|
1.111
x
|
Free Cash Flow
1 |
85.3
|
-776
|
47.9
|
9.42
|
297
|
-133
|
ROE (net income / shareholders' equity)
|
14.3%
|
11.5%
|
-14.6%
|
29%
|
78.1%
|
15.7%
|
ROA (Net income/ Total Assets)
|
4.46%
|
3.88%
|
3.06%
|
10.7%
|
28.6%
|
6.59%
|
Assets
1 |
700.2
|
841.6
|
-1,442
|
885.1
|
1,695
|
4,120
|
Book Value Per Share
2 |
1.600
|
1.730
|
1.500
|
2.000
|
2.850
|
5.950
|
Cash Flow per Share
2 |
0.0100
|
0.2800
|
0.3300
|
0.2200
|
0.4900
|
0.1500
|
Capex
1 |
11.1
|
652
|
27.7
|
60.6
|
72
|
165
|
Capex / Sales
|
4.5%
|
220.74%
|
2.16%
|
5.09%
|
3.19%
|
7.28%
|
Announcement Date
|
4/27/18
|
4/25/19
|
4/29/20
|
4/28/21
|
4/29/22
|
3/27/23
|
|
1st Jan change
|
Capi.
|
---|
| -21.57% | 917M | | +2.65% | 78.54B | | +1.82% | 30.31B | | +12.30% | 18.58B | | -10.05% | 11.56B | | +6.00% | 11.11B | | -7.50% | 9.81B | | +6.40% | 9.69B | | +5.61% | 9.3B | | +6.40% | 8.33B |
Diversified Chemicals
|